Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13756 | 752 | 37.7 | 80% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 40 | 31853 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//AIDS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | EXPOSED UNINFECTED | Author keyword | 11 | 60% | 2% | 12 |
| 2 | HESN | Author keyword | 7 | 67% | 1% | 6 |
| 3 | IMMUNOBIOL HIV UNIT | Address | 3 | 45% | 1% | 5 |
| 4 | JC WILT INFECT DIS | Address | 3 | 60% | 0% | 3 |
| 5 | HIV IMMUNOL | Address | 2 | 22% | 1% | 10 |
| 6 | CLIN SEROIMMUNOL | Address | 2 | 67% | 0% | 2 |
| 7 | HIV EXPOSED SERONEGATIVE | Author keyword | 2 | 67% | 0% | 2 |
| 8 | SALIVA ANTIBODIES | Author keyword | 2 | 67% | 0% | 2 |
| 9 | URINARY ANTIBODIES | Author keyword | 2 | 67% | 0% | 2 |
| 10 | COLLECTION DEVICE | Author keyword | 2 | 40% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | EXPOSED UNINFECTED | 11 | 60% | 2% | 12 | Search EXPOSED+UNINFECTED | Search EXPOSED+UNINFECTED |
| 2 | HESN | 7 | 67% | 1% | 6 | Search HESN | Search HESN |
| 3 | HIV EXPOSED SERONEGATIVE | 2 | 67% | 0% | 2 | Search HIV+EXPOSED+SERONEGATIVE | Search HIV+EXPOSED+SERONEGATIVE |
| 4 | SALIVA ANTIBODIES | 2 | 67% | 0% | 2 | Search SALIVA+ANTIBODIES | Search SALIVA+ANTIBODIES |
| 5 | URINARY ANTIBODIES | 2 | 67% | 0% | 2 | Search URINARY+ANTIBODIES | Search URINARY+ANTIBODIES |
| 6 | COLLECTION DEVICE | 2 | 40% | 1% | 4 | Search COLLECTION+DEVICE | Search COLLECTION+DEVICE |
| 7 | HIV RESISTANCE | 2 | 16% | 1% | 11 | Search HIV+RESISTANCE | Search HIV+RESISTANCE |
| 8 | CERVICAL SECRETIONS | 1 | 38% | 0% | 3 | Search CERVICAL+SECRETIONS | Search CERVICAL+SECRETIONS |
| 9 | EXPOSED UNINFECTED INDIVIDUALS | 1 | 38% | 0% | 3 | Search EXPOSED+UNINFECTED+INDIVIDUALS | Search EXPOSED+UNINFECTED+INDIVIDUALS |
| 10 | ANTI CCR5 ANTIBODIES | 1 | 100% | 0% | 2 | Search ANTI+CCR5+ANTIBODIES | Search ANTI+CCR5+ANTIBODIES |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PLASMA IGA | 15 | 62% | 2% | 16 |
| 2 | INTRAVASCULAR DRUG USERS | 13 | 69% | 1% | 11 |
| 3 | SERONEGATIVE PARTNERS | 13 | 47% | 3% | 20 |
| 4 | SERONEGATIVE INDIVIDUALS | 11 | 43% | 3% | 20 |
| 5 | UNINFECTED INDIVIDUALS | 7 | 32% | 2% | 18 |
| 6 | TESTING SALIVA | 6 | 71% | 1% | 5 |
| 7 | SALIVARY INHIBITION | 6 | 100% | 1% | 4 |
| 8 | KENYAN SEX WORKERS | 5 | 36% | 2% | 12 |
| 9 | EXPOSED SERONEGATIVE INDIVIDUALS | 5 | 45% | 1% | 9 |
| 10 | MUCOSAL IGA | 5 | 41% | 1% | 9 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals | 2004 | 66 | 105 | 61% |
| Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN) | 2011 | 29 | 131 | 36% |
| Immunologic uniqueness of the genital tract: Challenge for vaccine development | 2005 | 79 | 59 | 47% |
| The 'immunologic advantage' of HIV-exposed seronegative individuals | 2009 | 42 | 150 | 42% |
| Host Factors Involved in Low Susceptibility to HIV Infection | 2011 | 9 | 104 | 50% |
| Mucosal Correlates of Protection in HIV-1-Exposed Sero-negative Persons | 2014 | 2 | 111 | 46% |
| Methods for Evaluation of Humoral Immune Responses in Human Genital Tract Secretions | 2011 | 7 | 29 | 52% |
| Immune quiescence: a model of protection against HIV infection | 2013 | 3 | 60 | 45% |
| Oral transmission of HIV, reality or fiction? An update | 2006 | 44 | 80 | 36% |
| SEROLOGICAL DIAGNOSIS OF HIV-INFECTION USING ORAL FLUID SAMPLES | 1994 | 36 | 25 | 88% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IMMUNOBIOL HIV UNIT | 3 | 45% | 0.7% | 5 |
| 2 | JC WILT INFECT DIS | 3 | 60% | 0.4% | 3 |
| 3 | HIV IMMUNOL | 2 | 22% | 1.3% | 10 |
| 4 | CLIN SEROIMMUNOL | 2 | 67% | 0.3% | 2 |
| 5 | CATTEDRA IMMUNOL | 2 | 14% | 1.7% | 13 |
| 6 | UNITE IMMUNOL MICROBIENNE | 1 | 38% | 0.4% | 3 |
| 7 | MEDUNIT INFECT DIS | 1 | 30% | 0.4% | 3 |
| 8 | MEDINFECT DIS UNIT | 1 | 19% | 0.7% | 5 |
| 9 | GAY MENS HLTH CLIN VENHALSAN | 1 | 40% | 0.3% | 2 |
| 10 | GRP INFETTARE | 1 | 40% | 0.3% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000170421 | SEXUALLY TRANSMITTED VIRUS//MICHAEL DEGROOTE LEARNING DISCOVERY//HUMAN CERVIX |
| 2 | 0.0000146558 | SPERM WASHING//GRP HUMAN FERTIL//HIV SHEDDING |
| 3 | 0.0000113035 | HGP 30//VACCINE DEV BRANCH//HIV 1 IMMUNOGEN |
| 4 | 0.0000106576 | PARTNERS AIDS//HIV PATHOGENESIS PROGRAMME//DORIS DUKE MED |
| 5 | 0.0000088404 | MICROBIAL TRANSLOCATION//HIV ENTEROPATHY//ISOSPORA BELLI |
| 6 | 0.0000084785 | DMBT1//SALIVARY AGGLUTININ//GP 340 |
| 7 | 0.0000080200 | SIV//SHIV//SIMIAN IMMUNODEFICIENCY VIRUS |
| 8 | 0.0000076389 | MICROBICIDE//MICROBICIDES//NONOXYNOL 9 |
| 9 | 0.0000074091 | HAIRY LEUKOPLAKIA//ORAL HAIRY LEUKOPLAKIA//ORAL CANDIDIASIS |
| 10 | 0.0000068078 | CCR5//MARAVIROC//CCR5 ANTAGONIST |